Facts about ketamine
Ketamine is a medication which has commonly been used for general anesthesia for several decades. More recently, studies have shown its potent anti-depressant qualities, making it an effective medication for treatment-resistant depression. Low-dose ketamine is a safe, FDA-approved medication that can be administered intravenously in the outpatient clinic setting.
How ketamine works
Ketamine is administered intravenously, and it therefore works more quickly most antidepressants. Ketamine works by blocking NMDA receptors for glutamate and is absorbed and distributed into the target areas very quickly. It can sometimes produce a sense of being in a dissociative state during treatment. The exact mechanism through which ketamine alleviates depression is yet to be completely understood. However, its effectiveness as an antidepressant for treatment-resistant depression is evident.
How quickly are results seen?
One of the key benefits of ketamine infusion therapy is the rapidity with which its effects are seen. Some patients report noting effects of this therapy after the first few treatments.
Does research support the use of ketamine infusion for depression?
There is abundant research that validates the effectiveness of ketamine use as an anti-depressant. On March 1, 2017, the Journal of the American Medical Association Psychiatry published a consensus statement that endorses the use of ketamine for depression, and other mood disorders.
Ketamine infusion therapy is no doubt a very effective medication for treatment-resistant depression. Our highly trained providers administer ketamine treatments when indicated and continue to receive a plethora of testimonials of its effectiveness.